Skip to content
NEJM Interviews cover art

All Episodes

NEJM Interviews — 958 episodes · page 5 of 10

#
Title
401

NEJM Interview: Prof. Scott Burris on the importance of studying the health effects of laws, including laws related to Covid-19.

402

Vaccination in Nursing Homes and New Pulmonary/Critical Care Research

403

NEJM Interview: Dr. Theresa Williamson on strategies for reducing the burden of the minority tax in academic medicine.

404

Vaccination and Variants in the U.S. and South Africa

405

NEJM Interview: Dr. Kimberly Sue on federal health policy surrounding harm-reduction approaches to substance use.

406

India’s Covid-19 Crisis

407

NEJM Interview: Dr. N. Ewen Wang on threats to the health and well-being of immigrant children.

408

Advice for Clinicians on Covid-19 Vaccines and Social Restrictions

409

NEJM Interview: Dr. Joel Negin on the anniversary of sweeping firearm-injury prevention efforts in Australia and lessons for the rest of the world.

410

Covid-19 Vaccines and Pregnancy — A Conversation with CDC Director Rochelle Walensky

411

NEJM Interview: Dr. Neil Aggarwal on strategies for enhancing the effectiveness of the Biden administration’s equity agenda.

412

Vaccine Successes and Vaccine Adverse Events

413

NEJM Interview: Dr. Andrew Ryan on new legislation to prevent patients from receiving large and unexpected medical bills.

414

Antibody Responses to Natural Infection and Vaccination

415

NEJM Interview: Dr. Ingrid Katz on promotion and acceleration of global access to Covid-19 vaccines.

416

Delivering Covid-19 Vaccines to Minority Communities

417

NEJM Interview: Dr. Christopher Elias on progress in containing infectious diseases and steps for preventing and countering new threats.

418

What Earlier Epidemics Teach Us about Covid-19

419

NEJM Interview: Dr. Paul Offit on how more than two centuries of vaccine advances have paved the way for Covid-19 vaccines.

420

Efficacy of Current Covid-19 Vaccines against Variant Viruses

421

NEJM Interview: Dr. Jane Zhu on the growth of private-equity investment in medical practices.

422

The Implications of Changes in the Structural Biology of SARS-CoV-2

423

NEJM Interview: Dr. Suchita Rastogi on undertaking medical training as a student with a chronic illness.

424

A New SARS-CoV-2 Vaccine and a New Look at Treatment

425

NEJM Interview: Dr. Gary Gibbons on progress in understanding, preventing, and treating atherosclerotic cardiovascular disease.

426

The Real-World Effectiveness of Covid-19 Vaccination

427

NEJM Interview: Dr. Thomas Lee on the work that health care organizations will need to take on to ensure effective delivery of Covid-19 vaccines.

428

Viral Variants and Covid-19

429

NEJM Interview: Dr. Perri Klass on vaccinating children against Covid-19, including lessons from measles vaccination campaigns.

430

Does Vaccination Mean the End of Masking and Social Distancing?

431

NEJM Interview: Dr. William Feldman on a new federal price-transparency rule and legal challenges to efforts to increase access to pricing information.

432

Covid-19 and the States — A Conversation with Ralph Northam

433

NEJM Interview: Dr. Julie Gerberding on the past half-century of vaccine development and policy.

434

A Covid-19 Conversation with Anthony Fauci

435

NEJM Interview: Dr. Michael Incze on building multidisciplinary care teams for endocarditis and reducing stigma related to substance use.

436

An International Look at Covid-19

437

NEJM Interview: Dr. Pardis Sabeti on the importance of testing during an epidemic and why testing approaches in the United States have fallen short.

438

Covid-19 in South Africa and a New SARS-CoV-2 Variant

439

NEJM Interview: Corey Davis on the recent federal settlement with Purdue Pharma over its actions to increase prescriptions of its opioid medications.

440

Planning for the SARS-CoV-2 Vaccine Rollout

441

NEJM Interview: Dr. Charles Rotimi on advances in human molecular genetics and genomics.

442

A Look at Covid-19 Prevention and Care in 2020

443

NEJM Interview: Dr. Paula Chatterjee on the role of safety-net hospitals and the challenges associated with defining these facilities.

444

NEJM Interview: Dr. Raphael Rush on consent and the gift that patients give when they allow trainees to learn on their bodies.

445

Covid-19 Vaccine Fundamentals

446

NEJM Interview: Dr. Daphna Stroumsa on transgender rights, including coverage of gender-affirming health care.

447

SARS-CoV-2 Vaccination and Vulnerable Populations

448

NEJM Interview: Dr. Jay Hoofnagle on the discovery of hepatitis C and progress in preventing and treating chronic infection.

449

Caring for Hospitalized Patients with Covid-19

450

NEJM Interview: Dr. Shiriki Kumanyika on U.S. and global strategies for addressing obesity and related health threats.

451

New Studies of Covid-19 Transmission

452

NEJM Interview: Dr. Sonja Rasmussen on guidance related to pursuing or delaying pregnancy during a public health emergency.

453

Covid-19 in Europe and New Information on Vaccines

454

NEJM Interview: Dr. Elizabeth Rourke on practicing primary care over the Internet during the Covid-19 pandemic.

455

An Update from Operation Warp Speed

456

NEJM Interview: Dr. Holly Taylor on the ethical issues involved in conducting Covid-19 vaccine research in correctional facilities.

457

What the U.S. Response to Covid-19 Looks Like Today

458

NEJM Interview: Dr. Linda McCauley on historical and current concerns related to the health of U.S. veterans.

459

A New Monoclonal Antibody for Covid-19

460

NEJM Interview: Dr. Jason Schwartz on processes for determining the safety and efficacy of Covid-19 vaccine candidates and for distributing vaccines.

461

Tocilizumab and Covid-19

462

NEJM Interview: Dr. Jonathan Oberlander on health reform and the 2020 elections.

463

Vaccinology and Covid-19

464

NEJM Interview: Drs. Sherry Glied and Mark Pauly on what U.S. health policy could look like in the coming years under a Biden or a Trump administration.

465

Covid-19 and the President

466

NEJM Interview: Dr. Michael Chernew on the role of markets in improving the efficiency of health care delivery.

467

Covid-19 Testing and the Individual Physician

468

NEJM Interview: Dr. Linda Fried on advances in research on aging and ongoing efforts to provide older Americans with high-quality prevention and care.

469

Eight Months of Action and Inaction against Covid-19

470

NEJM Interview: Dr. Anthony Fauci on empathy, transparency, and global disease outbreaks

471

NEJM Interview: Dr. Matthew Fiedler on disagreement about the role of government in health insurance and health care in the United States.

472

Operation Warp Speed and Covid-19 Therapeutics

473

NEJM Interview: Dr. Michael Greene on considerations regarding the consent process for procedures performed by medical students and residents.

474

Guidelines for Covid-19 Vaccine Deployment

475

NEJM Interview: Dr. Michele Evans on the role that public policies have played in exacerbating health inequities in the United States.

476

Understanding Antibody Testing in Covid-19

477

NEJM Interview: Dr. Richard Schilsky on milestones in the prevention and treatment of cancer in the United States.

478

Operation Warp Speed and Covid-19

479

NEJM Interview: Dr. Elizabeth McGlynn on why efforts to improve health care quality have often been unsuccessful and where we can go from here

480

Covid-19 and Contact Tracing

481

NEJM Interview: Dr. Justin Berk on starting patients recently released from incarceration on treatment for opioid use disorder.

482

Building a Successful Public Health Response to Covid-19

483

NEJM Interview: Dr. Katherine Baicker on assessments of health care spending in the United States and moving toward higher-value use of resources.

484

The Impact of Covid-19 on Patients with Other Diseases, with Arnold Epstein

485

NEJM Interview: Dr. Donald Berwick on the history and challenges of measuring and improving health care quality in the United States.

486

New SARS-CoV-2 Vaccine Results, with Peter Piot

487

How Policy Shapes Health Care

488

Dexamethasone and Covid-19

489

NEJM Interview: Dr. Caroline Buckee on the uses — and limitations — of epidemiologic modeling to predict the spread of Covid-19.

490

Covid-19 Vaccine Development

491

NEJM Interview: Dr. Michelle Morse on how academic medical centers can engage with social movements to confront inequities in health care practices.

492

Acute Lung Injury in Covid-19

493

NEJM Interview: Dr. Martin Roland on opportunities for using socially oriented interventions when illnesses are influenced by social circumstances.

494

A Covid-19–Related Syndrome in Children

495

NEJM Interview: Dr. Anthony Fauci on progress made during the past four decades of the HIV/AIDS pandemic and ongoing efforts to end this threat.

496

NEJM Interview: Dr. Eric Rubin and Dr. Lindsey Baden on the challenges of safe reopening

497

NEJM Interview: Dr. Pamela Hartzband on lessons from organizational psychology for ameliorating physician burnout.

498

NEJM Interview: Dr. Eric Rubin and Dr. Lindsey Baden on a look at SARS-CoV-2 transmission

499

NEJM Interview: Dr. Debra Weinstein on the announcement that scores for Step 1 of the U.S. Medical Licensing Examination will be reported as pass or fail.

500

NEJM Interview: Dr. Eric Rubin, Dr. Lindsey Baden, and Dr. Michele Evans on the impact of Covid-19 on minority communities